Fahad Razak

Dr. Fahad Razak, MD, MSc, FRCPC is a Canadian epidemiologist based in Toronto, Ontario.

He has a multidisciplinary background including biomedical engineering, epidemiology and public health, and a medical degree with specialization in general internal medicine.

Razak is a David E. Bell Fellow at the Harvard Center for Population and Development Studies at Harvard University's School of Public Health.¹⁾

As a Bell Fellow, Fahad studied the causes and consequences of the changing shape of chronic disease risk factor distributions at the population level, with special focus on body weight. He worked with Harvard Professor of Population Health and Geography S.V. Subramanian to show that in low and middle income countries, reliance on conventional and widely used metrics of population change may underestimate the degree of weight gain among high weight individuals and overestimate weight gain in low weight individuals. He subsequently extended these findings to other risk factors for chronic disease and examine the patterning of these changes on social and demographic factors.

Razak co-leads Ontario Health's General Medicine Quality Improvement Network (GeMQIN), which focuses on improving the care of hospitalized medical patients.²⁾

Razak is an Assistant Professor at the Dalla Lana School of Public Health under the University of Toronto.³⁾ He is also a faculty member of the new Institute for Pandemics.⁴⁾

Razak is an internist at St. Michael's Hospital under Unity Health Toronto.⁵⁾ He is also a research scientist at the Li Ka Shing Knowledge Institute, located at St. Michael's.⁶⁾

He has received research funding from the St. Michael's Hospital Foundation.⁷⁾

Razak is co-lead and co-founder of GEMINI, a “big data collaborative” that serves as a hospital data & analytics study program.⁸⁾ The program is a collaboration with Ontario Health.

In December 2020, Razak was announced as the 2021 PSI Graham Farquharson Knowledge Translation Fellow under the PSI Foundation.⁹⁾

Razak is a Principal Investigator of the Canadian COVID-19 Prospective Cohort Study (CanCOV), funded by the CIHR.¹⁰⁾

During the COVID-19 pandemic, Razak has served as a member of the Ontario COVID-19 Science Advisory Table.¹¹⁾ On April 29, 2022, it was announced that Razak would replace the outgoing Peter Juni as the OST's Scientific Director.¹²⁾

Razak claims to have received greater than $25 million in grants from the Canadian Institutes of Health Research (CIHR), National Sciences and Engineering Research Council (NSERC), the National Institutes of Health (NIH),¹³⁾ and the Canadian Cancer Society.¹⁴⁾

Razak received funding from the Toronto COVID-19 Action Initiative, a $6,000,000 fund offered to faculty at the University of Toronto and its affiliated hospitals.¹⁵⁾ The funds were to be used for research into topics including (but not limited to) diagnostics, therapeutics, vaccines, or technologies for clinical management (e.g. ventilators, masks).¹⁶⁾

Razak has also received research funding from the Canadian Frailty Network,¹⁷⁾ including related to COVID-19.¹⁸⁾

In 2019, Razak received a New Investigator Award from the Canadian Society of Internal Medicine.¹⁹⁾

• https://www.theglobeandmail.com/opinion/article-can-we-follow-the-british-model-to-tame-the-virus-by-canada-day/
• https://www.theglobeandmail.com/opinion/article-canada-needs-new-rules-now-for-fully-vaccinated-people/
• https://muckrack.com/fahad-razak/articles